Work

Phase 1/2 Study of Brentuximab Vedotin in Pediatric Pts with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 HL Data

Year: 2014

Type: article

Study design: Clinical Trial

Source: Klinische Pädiatrie

DOI: 10.1055/s-0034-1371149

Authors: F Locatelli, K Neville, A Rosolen, J Landman-Parker, N Aladjidi, A Beishuizen, S Daw, L Gore, ARK Franklin, A Fasanmade, J Wang, J Sachs, C Mauz-Körholz

Institutions: University of Pavia, Bambino Gesù Children's Hospital, Children's Mercy Hospital, University of Padua, Hôpital Armand-Trousseau, Hôpital Pellegrin, Erasmus MC - Sophia Children’s Hospital, University College Hospital, Children's Hospital Colorado, The University of Texas MD Anderson Cancer Center, Martin Luther University Halle-Wittenberg

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2035915324

FWCI: 0.986

Cites:

Cited by: 4

Related to: 10